| 000 | 01320 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515013639.0 | ||
| 264 | 0 | _c20071002 | |
| 008 | 200710s 0 0 chi d | ||
| 022 | _a0253-3766 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Yan | |
| 245 | 0 | 0 |
_a[Current status of the study of the mechanism of epidermal growth factor receptor targeting drug therapy and their related markers]. _h[electronic resource] |
| 260 |
_bZhonghua zhong liu za zhi [Chinese journal of oncology] _cSep 2005 |
||
| 300 |
_a573-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 700 | 1 | _aXu, Jian-ming | |
| 700 | 1 | _aSong, San-tai | |
| 773 | 0 |
_tZhonghua zhong liu za zhi [Chinese journal of oncology] _gvol. 27 _gno. 9 _gp. 573-6 |
|
| 999 |
_c16053357 _d16053357 |
||